PT-141 users describe greater desire, sickness, and other unwanted effects.

Feeling ill can outweigh a small improvement in desire

A queasy stomach can take away the pleasure someone hoped to regain. PT-141 approval concerns women with a particular distressing loss of sexual interest. The approval doesn't cover your erection difficulty or every other sexual concern. I'd ask which unwanted effects matter most with your own medical history.

Women in studies wanted sex a little more, but often felt sick. Some women stopped because the relief wasn't worth feeling sick. Blood pressure rose briefly, and uncommon liver problems were also reported. Hot red skin, headaches, sore shot sites, and tiredness appear in people's accounts too.

People trying laboratory products on themselves describe wanting sex more and enjoying touch more. A few say they felt closer to their partner. Men describe unexpected erections, although male treatment falls outside the approval. Nobody checked these accounts against placebo, leaving you uncertain about what caused each experience.

People describe experiences that comparison studies haven't checked

These are accounts from people testing laboratory products on themselves for research; no study with placebo shots has checked or confirmed what they describe. A placebo injection contains no medicine and allows researchers to compare responses. The accounts come from public discussions of people's own use. You can't work out your chance of benefit from how often an experience is mentioned.

What people liked about sex

• Wanting sex more was mentioned most often. People described interest returning to their thoughts. The report doesn't promise that your desire will return.
• Touch sometimes felt stronger and more exciting. People said sexual excitement began with little prompting. No study checked whether the medicine caused these experiences.
• Orgasm sometimes came more easily or felt stronger. Orgasm is the climax during sex. People often linked greater pleasure with stronger desire.
• Men often described erections arriving unexpectedly. Male use isn't included in the drug's approval. The accounts aren't proof of dependable help with erections.
• Sexual interest could build slowly and continue into the next day. Some said their greater sexual interest lasted overnight. These descriptions didn't establish how long erections lasted.
• Some described feeling closer to a partner. They mentioned paying more attention during intimacy. Many felt no difference in closeness, and the cause wasn't checked.

What people found unpleasant

• Sickness was the most frequent complaint. Some accounts described vomiting as well as queasiness. Nausea could wipe out the pleasure a person hoped for.
• Heat and redness often affected the upper body. People sometimes felt sick while their skin felt hot. This brief redness differs from skin becoming persistently darker.
• Headaches were another frequent complaint. People usually said the pain passed fairly quickly. A short headache can still make sex less appealing to you.
• The injection spot could hurt or swell. People also mentioned a small area turning red. Your risk of that reaction can't be counted from these accounts.
• Some people noticed no increase in desire or excitement. They could still suffer unwanted effects. Your response can't be predicted from their disappointment.
• Tingling and restless legs were mentioned less often. People described pins and needles or briefly feeling uneasy. The accounts didn't include study checks of the cause.
• Some people felt sleepy or drained afterward. Tiredness outlasted the first sensations they noticed. The reports don't establish a usual length of time.
• Occasional reports described darkening that didn't fully fade. Skin, gums, freckles, and moles could become darker. Repeated use appeared in some of those accounts.

Studies also found risks involving the heart, skin, and liver

Approval concerns women distressed by loss of previously normal desire. Interest stayed low with different partners and settings before menopause, the permanent end of periods. Men, older women, and improved performance fall outside approval. ^{[11] [6] [3]}

Blood pressure rises briefly and the pulse slows a little. Heart disease or uncontrolled high blood pressure rules out treatment. Tell the doctor about any heart problems you've had. ^{[11] [16] [17]}

Roughly four women in every ten reported sickness during longer use. Some vomited, and nausea often made treatment too unpleasant to continue. Ask how that risk compares with the benefit. ^{[4] [18] [3]}

Stopping the medicine doesn't always remove the darkening. Skin, gums, moles, and freckles can deepen in color. This is more likely when a person's skin was already darker, and differs from brief redness. ^[11]

Most liver blood-test rises were mild, though rare injury was reported. LiverTox describes higher levels of liver enzymes, proteins that help cells work. Your doctor can explain what those blood tests mean. ^[10]

Laboratory bottles don't assure you of contents or strength. A related drug, melanotan-II, was linked to serious illness and muscle damage. The case doesn't establish harm from bremelanotide, but uncertain supplies add risks. ^{[19] [20]}

Women lost weight and ate less in early experiments. Frequent shots were tested in women with obesity, meaning very high body weight. The findings don't make this an approved medicine for weight loss. ^{[21] [22]}

Pregnancy and breastfeeding safety hasn't been shown in people. Lack of evidence doesn't prove a baby was harmed. Doctors can't assume safety when that evidence is missing.

PT-141 development began after sexual effects in tanning research

An early tanning drug, melanotan-II, unexpectedly produced sexual effects during testing. Researchers then developed PT-141 to study sexual problems. Researchers first tried nose sprays and later used shots in men and women. The researchers later focused their studies on women upset about their lost interest in sex.

The shots gained federal approval in 2019 as bremelanotide for one defined indication. Those women had lost previously normal desire regardless of partner or setting. Your symptoms may differ greatly from the difficulty they had. That approval can't establish help for every sexual problem. ^{[23] [24] [6] [3] [11] [25] [1]}